I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues

Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products

November 01, 2020 Arnall Golden Gregory LLP Season 1 Episode 2
I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues
Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
Show Notes

In this episode, Alan G. Minsk, partner and leader of the Food & Drug practice team, is joined by Brian A. Teras, partner of the Corporate & Securities practice team. They provide an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process.